Gene editing advance shows promise as long-lasting treatment for rare liver disease
Researchers have taken an important step toward solving one of the biggest challenges in gene therapy for children with metabolic liver disorders: growth itself. As a child's liver grows, some gene therapies that once worked can gradually lose their effect because the treated cells are eventually outnumbered by new, untreated ones.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
